This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
03/26/15 - 3:59:50 PM ET (BATS BZX Real-time Price)
Div Yield: --
TECH Day's Range
TECH 52 Week Range
TECH Business Summary
Bio-Techne Corporation develops, manufactures, and sells biotechnology products and clinical diagnostic controls worldwide. It operates in two segments, Biotechnology and Clinical Controls.View TECH key stats
Bio-Techne Corp - TECH - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Bio-Techne Corp as a
Buy with a ratings score of A-.
Report Snippet: We rate Bio-Techne Corp (TECH) a Buy.
This is based on the convergence of positive investment measures, which should help this stock outperform the majority
of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance,
growth in earnings per share, revenue growth, notable return on equity and expanding profit margins. Although the company
may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.